YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3 - TransCon CNP NDA submission for achondroplasia planned for Q1 2025 ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Welcome to Tarsus’ Third Quarter 2024 Financial Results ...

Some are more clear than others. President-elect Donald Trump ’s nomination of Robert F. Kennedy Jr. as head of the ...

President-elect Donald Trump has selected Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of ...

Kennedy believes that vaccines cause autism and wants to use his perch to carry out further testing.

City Cast Nashville is the easiest way to stay updated on what's happening in Nashville. Their daily podcast and newsletter ...

Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company developing innovative medicines for ...

In today’s world, many men seek solutions for enhancing their sexual health and overall vitality. One product that has ...

The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...

Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that ...

The president of the anti-abortion group SBA Pro-Life America, said “there's no question that we need a pro-life HHS ...